Adipocyte fatty acid binding protein (A-FABP), an adipokine that has been implicated in lipid metabolism, lipolysis, and insulin sensitivity, can be used to predict the incidence of metabolic syndrome (MetS) and type 2 diabetes mellitus (DM). This evidence concerns the gene INS and metabolic syndrome.